FDA Import Refusal 9VB-0130015-9/22/1B — Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd.
The FDA refused shipment 9VB-0130015-9/22/1B from Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd. (China) on April 14, 2023. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 3280,75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- April 14, 2023
- Country
- China
- Product Category
- Drugs and Biologics
- Product Code
- 66VBJ99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 3280,75